Abstract:Amyloid precursor protein (APP) is a type I transmembrane protein associated with the pathogenesis of Alzheimer's disease (AD). APP is characterized by a large extracellular domain and a short cytosolic domain termed the APP intracellular domain (AICD). During maturation through the secretory pathway, APP can be cleaved by proteases termed α, β, and γ-secretases. Sequential proteolytic cleavage of APP with β and γ-secretases leads to the production of a small proteolytic peptide, termed Aβ, which is amyloidogenic and the core constituent of senile plaques. The AICD is also liberated from the membrane after secretase processing, and through interactions with Fe65 and Tip60, can translocate to the nucleus to participate in transcription regulation of multiple target genes. Protein-protein interactions involving the AICD may affect trafficking, processing, and cellular functions of holo-APP and its C-terminal fragments. We have recently shown that AICD can aggregate in vitro, and this process is inhibited by the AD-implicated molecular chaperone ubiquilin-1. Consistent with these findings, the AICD has exposed hydrophobic domains and is intrinsically disordered in vitro, however it obtains stable secondary structure when bound to Fe65. We have proposed that ubiquilin-1 prevents inappropriate inter- and intramolecular interactions of AICD, preventing aggregation in vitro and in intact cells. While most studies focus on the role of APP in the pathogenesis of AD, the role of AICD in this process is not clear. Expression of AICD has been shown to induce apoptosis, to modulate signaling pathways, and to regulate calcium signaling. Over-expression of AICD and Fe65 in a transgenic mouse model induces Alzheimer's like pathology, and recently AICD has been detected in brain lysates by western blotting when using appropriate antigen retrieval techniques. To facilitate structural, biochemical, and biophysical studies of the AICD, we have developed a procedure to produce recombinantly large amounts of highly pure AICD protein. We further describe a method for inducing the in vitro thermal aggregation of AICD and analysis by atomic force microscopy. The methods described are useful for biochemical, biophysical, and structural characterization of the AICD and the effects of molecular chaperones on AICD aggregation.

Purification and aggregation of the amyloid precursor protein intracellular domain

Advances in Understanding the Β-Amyloid Precursor Protein Intracellular Domain

The AICD interactome: implications in neurodevelopment and neurodegeneration

The progress in researching APP intracellular domain (AICD)

Wnt/β-catenin Signal Pathway Stabilizes APP Intracellular Domain (AICD) and Promotes Its Transcriptional Activity

Characterization of Amyloid-Β Precursor Protein Intracellular Domain-Associated Transcriptional Complexes in SH-SY5Y Neurocytes

A Study of AID and Interacting Protein by Yeast Two-hybrid

Genetic Dissection of the Amyloid Precursor Protein in Developmental Function and Amyloid Pathogenesis

Examination of the interactions of the amyloid precursor protein carboxyl terminus to intracellular protein: possible role in apoptosis

The amyloid precursor protein: beyond amyloid

Impact of membrane lipid composition on the structure and stability of the transmembrane domain of amyloid precursor protein

APP and β-amyloid modulate protein aggregation and dissociation from recycling endosomal and exosomal membranes

Amyloid Precursor Protein Revisited

Nanodisc Reconstitution and Characterization of Amyloid-β Precursor Protein C99

Expression, Purification and the Biological Activites of C-terminal Fragment CTFβ

Molecular Integrative Analysis of the Inhibitory Effects of Dipeptides on Amyloid β Peptide 1–42 Polymerization

Macromolecular and small-molecule modulation of intracellular Aβ42 aggregation and associated toxicity.

Converting the Amyloidogenic Islet Amyloid Polypeptide into a Potent Nonaggregating Peptide Ligand by Side Chain-to-Side Chain Macrocyclization

[The Interaction of the Intracellular Domain of Beta-Amyloid Precursor Protein with JKTBP2].

Regulation Of Alzheimer'S Disease Amyloid-Beta Formation By Casein Kinase I